Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Operations (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Cash from Operations for 15 consecutive years, with 1672649.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Cash from Operations rose 34.8% year-over-year to 1672649.0, compared with a TTM value of 7645532.0 through Mar 2025, up 24.52%, and an annual FY2025 reading of 7645532.0, up 24.52% over the prior year.
  • Cash from Operations was 1672649.0 for Q1 2025 at Aethlon Medical, up from 2010788.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1672649.0 in Q1 2025 and bottomed at 3099078.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 2369779.88, with a median of 2377835.0 recorded in 2023.
  • The sharpest move saw Cash from Operations tumbled 88.01% in 2021, then surged 34.8% in 2025.
  • Year by year, Cash from Operations stood at 2718118.0 in 2021, then rose by 28.22% to 1951114.0 in 2022, then decreased by 21.87% to 2377835.0 in 2023, then increased by 15.44% to 2010788.0 in 2024, then grew by 16.82% to 1672649.0 in 2025.
  • Business Quant data shows Cash from Operations for AEMD at 1672649.0 in Q1 2025, 2010788.0 in Q4 2024, and 2214558.0 in Q3 2024.